Forex
Medacta Reports Above-Market Revenue Growth of 9.7% in H1 2026
Medacta Group SA reported continued above-market revenue growth of 9.7% in constant currency for H1 2026, exceeding a record high comparable base.
The company's revenue increased to Euro 368 million in the first half of 2026, with growth across all business lines and geographies.
Medacta attributes this success to its focus on differentiating innovations, medical education, and the attraction of new surgeons through its expanded sales force.